Cargando…
Evaluation of dextromethorphan with select antidepressant therapy for the treatment of depression in the acute care psychiatric setting
INTRODUCTION: Dextromethorphan (DXM), an N-methyl-D-aspartate receptor antagonist, may have ketamine-like antidepressant effects. Dextromethorphan is extensively metabolized via cytochrome P450 (CYP) 2D6, and its half-life in extensive metabolizers is 2 to 4 hours. The purpose of this study was to e...
Autores principales: | Nofziger, Jill L., Paxos, Chris, Emshoff, Jessica, Mullen, Chanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
College of Psychiatric & Neurologic Pharmacists
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398352/ https://www.ncbi.nlm.nih.gov/pubmed/30842914 http://dx.doi.org/10.9740/mhc.2019.03.076 |
Ejemplares similares
-
Evaluation of oral antipsychotic supplementation of select second-generation long-acting injectable antipsychotics in an acute-care psychiatric setting
por: Alastanos, Jennifer N., et al.
Publicado: (2019) -
Involvement of Sigma-1 Receptors in the Antidepressant-like Effects of Dextromethorphan
por: Nguyen, Linda, et al.
Publicado: (2014) -
Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder
por: McCarthy, Brian, et al.
Publicado: (2023) -
Dextromethorphan improved cyclosporine-induced depression in mice model of despair
por: Mesripour, Azadeh, et al.
Publicado: (2020) -
Improvement of depressive symptoms, after a suicide attempt, with dextromethorphan/bupropion combination treatment in a patient with treatment‐resistant depression and psychiatric comorbidities
por: Pedraz‐Petrozzi, Bruno, et al.
Publicado: (2023)